首页> Oncoimmunology> Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： McA,Wouters

第一单位： Department of Gynecologic Oncology; University of Groningen; University Medical Center Groningen ; Hanzeplein ; Groningen, The Netherlands ; Department of Medical Microbiology; University of Groningen; University Medical Center Groningen ; Hanzeplein , Groningen, The Netherlands.

作者： McA,Wouters ^[1] ; E M,Dijkgraaf ^[2] ; M L,Kuijjer ^[3] ; E S,Jordanova ^[4] ; H,Hollema ^[5] ; Mjp,Welters ^[2] ; Jjm,van der Hoeven ^[2] ; T,Daemen ^[6] ; J R,Kroep ^[2] ; H W,Nijman ^[7] ; S H,van der Burg ^[2]

作者单位： Department of Gynecologic Oncology; University of Groningen; University Medical Center Groningen ; Hanzeplein ; Groningen, The Netherlands ; Department of Medical Microbiology; University of Groningen; University Medical Center Groningen ; Hanzeplein , Groningen, The Netherlands. ^[1] Department of ClinicalOncology; Leiden University Medical Center ; Albinusdreef , Leiden, The Netherlands. ^[2] Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute ; Boston, MA USA ; Department of Biostatistics; Harvard School of Public Health ; Boston, MA USA. ^[3] Center for Gynaecological Oncology Amsterdam ; VUMC, De Boelelaan , Amsterdam, The Netherlands. ^[4] Department of Pathology; University of Groningen; University Medical Center Groningen ; Hanzeplein , Groningen, The Netherlands. ^[5] Department of Medical Microbiology; University of Groningen; University Medical Center Groningen ; Hanzeplein , Groningen, The Netherlands. ^[6] Department of Gynecologic Oncology; University of Groningen; University Medical Center Groningen ; Hanzeplein ; Groningen, The Netherlands. ^[7]